Daiichi Sankyo Co. Ltd.'s Fiscal Year is From April To March - All Figures are in JPY, Billions.
The item "Cogs-Excluding-Depreciation-and-Amortization" stands at 413.09 Billion Japanese Yens for the trailing twelve months (TTM) period ending 06/30/2025.
Daiichi Sankyo Co. Ltd.'s first quarter result of 92.35 Billion JPY for the item "Cogs Excluding Depreciation and Amortization" represents a decrease of -2.11 percent compared to it's fourth quarter result of the company's last fiscal year.
Also, Daiichi Sankyo Co. Ltd.'s first quarter result of 92.35 Billion JPY for the item "Cogs Excluding Depreciation and Amortization" represents a decrease of -2.84 percent compared to it's first quarter result of last year.
Looking again at the trailing twelve months series (TTM), Daiichi Sankyo Co. Ltd.'s first quarter result of 413.09 Billion JPY for the item "Cogs Excluding Depreciation and Amortization" represents a decrease of -0.65 percent compared to it's fourth quarter result of the company's last fiscal year.
Regarding the One-Year-Change of the series, the current value constitutes an increase of 11.28 percent compared to the value the year prior.
The 1 year change in percent is 11.28.
The 3 year change in percent is 45.18.
The 5 year change in percent is 45.60.
The 10 year change in percent is 52.35.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Cogs Excluding Depreciation and Amortization | 905,699,262,464.00 |
![]() | Johnson & Johnson - Cogs Excluding Depreciation and Amortization | 486,508,953,600.00 |
![]() | AbbVie Inc - Cogs Excluding Depreciation and Amortization | 399,570,305,024.00 |
![]() | Roche Holding AG - Cogs Excluding Depreciation and Amortization | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Cogs Excluding Depreciation and Amortization | 280,205,508,085.11 |